|
[1]Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of nonalcoholic liver disease (revised version2010) [J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病分会脂肪肝和酒精性肝病学组.非酒精性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (2) :120-124.[2]FAN X, YU GH, ZHANG FK.The role of enhanced health education in the management of nonalcoholic fatty liver disease[J].J Clin Exp Med, 2011, 10 (3) :174-175. (in Chinese) 范昕, 于耕红, 张福奎.强化健康教育在非酒精性脂肪性肝病治疗中的作用[J].临床和实验医学杂志, 2011, 10 (3) :174-175.[3]LAZO M, CLARK JM.The epidemiology of nonalcoholic fatty liver disease:a global perspective[J].Semin Liver Dis, 2008, 28 (4) :339-350.[4]FAN JG, FARRELL GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol, 2009, 50 (1) :204-210.[5]ZHANG H, HE SM, SUN J, et al.Prevalence and etiology of abnormal liver function tests in adult population in Jilin, China[J].Int J Med Sci, 2011, 8 (3) :254-262.[6]SODERBERG C, STAL P, ASKLING J, et al.Decreased survival of subjects with elevated liver function tests during a 28-year follow-up period[J].Hepatology, 2010, 51 (2) :595-602.[7]CAMPOS GM, BAMBHA K, VITTINGHOFF E, et al.A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients[J].Hepatology, 2008, 47 (6) :1916-1923.[8]LEE YJ, LEE HR, SHIM JY, et al.Relationship between white blood cell count and nonalcoholic fatty liver disease[J].Dig Liver Dis, 2010, 42 (12) :888-894.[9]RUAN JW, YANG J, GAO LJ.Advances in the relationship between metabolic syndrome and nonalcoholic fatty liver disease[J].J Clin Hepatol, 2011, 27 (11) :1102-1104. (in Chinese) 阮建文, 杨京, 高丽娟.非酒精性脂肪性肝病与代谢综合征关系研究进展[J].临床肝胆病杂志, 2011, 27 (11) :1102-1104.[10]WU T, YIN SY, WANG HC, et al.The clinical features and risk factors of patient with metabolic syndrome combined with non-alcoholic fatty liver disease[J].J Clin Hepatol, 2011, 27 (10) , 1036-1040. (in Chinese) 吴涛, 尹守乙, 王宏长, 等.代谢综合征合并非酒精性脂肪性肝病患者的临床特点和危险因素[J].临床肝胆病杂志, 2011, 27 (10) :1036-1040.[11]HARRISON SA, OLIVER D, ARNOLD HL, et al.Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease[J].Gut, 2008, 57 (10) :1414-1417.[12]PANTSARI MW, HARRISON SA.Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase[J].J Clin Gastroenterol, 2006, 40 (7) :633-635.[13]YANG HR, KIM HR, KIM MJ.Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease[J].World J Gastroenterol, 2012, 18 (13) :1525-1530.[14]YOUNOSSI ZM, GRAMLICH T, MATTEONI CA, et al.Nonalcoholic fatty liver disease in patients with type 2 diabetes[J].Clin Gastroenterol Hepatol, 2004, 2 (3) :262-265.[15]KVILEKVAL K, LIN J, CHENG W, et al.Fatty acids as determinants of triglyceride and cholesteryl ester synthesis by isolated hepatocytes:kinetics as a function of various fatty acids[J].J Lipid Res, 1994, 35 (10) :1786-1794.[16]HARING R, WALLASCHOFSKI H, NAUCK H, et al.Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels[J].Hepatology, 2009, 50 (5) :1403-1411.[17]RUHL CE, EVERHART JE.Elevated serum alanine aminotransferase and gamma glutamyltransferase and mortality in the United States population[J].Gastroenterology, 2009, 136 (2) :477-485.[18]TAHAN V, CANBAKAN B, BALCI H, et al.Serum gammaglutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk[J].Hepatogastroenterology, 2008, 55 (85) :1433-1438.[19]BOSE T, VORUGANTI VS, TEJERO ME, et al.Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors[J].Exp Biol Med (Maywood) , 2009, 234 (12) :1519-1524.[20]CHANDOK N, MINUK G, WENGIEL M, et al.Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease[J].J Gastrointestin Liver Dis, 2012, 21 (1) :53-58.[21]GEORGE DK, GOLDWURM S, MACDONALD GA, et al.Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis[J].Gastroenterology, 1998, 114 (2) :311-318.[22]LI Y, XU C, YU C, et al.Association of serum uric acid level with non-alcoholic fatty liver disease:a cross-sectional study[J].J Hepatol, 2009, 50 (5) :1029-1034.[23]PETTA S, CAMMA C, CABIBI D, et al.Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther, 2011, 34 (7) :757-766.
|
DownLoad: